Clinical trial
Kappa Opioid Receptor Imaging in Depression (KOR Depression)
NCT02236702 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Kappa Opioid Receptor Imaging in Depression (KOR Depression)
- Lead sponsor
- NYU Langone Health
- Phase
- Observational
- Overall status
- Terminated
- Start date
- August 31, 2014
- Completion date
- February 29, 2016
- Enrollment
- 15 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.